Ausel, Inc.

SEC filing

Biotechnology · Carlsbad, CA

Form D on EDGAR

Amount raised$120Ksold at filing

Total offering$5M$4.9M still open

Investors in the raise1count reported to the SEC

FiledNov 4, 2026first sale Oct 22, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Nicholas AinslieExecutive Officer, Director

Paul Evan ShockleyExecutive Officer, Director

Prisco PiscitelliExecutive Officer

Paul AinslieDirector

Robert AinsliePromoter

Executive officers, directors and promoters as listed on the Form D.